Alexander A. Maini

1.5k total citations · 1 hit paper
20 papers, 979 citations indexed

About

Alexander A. Maini is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Alexander A. Maini has authored 20 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hepatology and 6 papers in Immunology. Recurrent topics in Alexander A. Maini's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (8 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Alexander A. Maini is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (8 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Alexander A. Maini collaborates with scholars based in United Kingdom, United States and Netherlands. Alexander A. Maini's co-authors include Derek W. Gilroy, James N. Fullerton, Amit A. Patel, Derek C. Macallan, Venetia Bigley, Becca Asquith, Lies Boelen, Anthony Rongvaux, Richard A. Flavell and Simon Yona and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and The FASEB Journal.

In The Last Decade

Alexander A. Maini

19 papers receiving 972 citations

Hit Papers

The fate and lifespan of ... 2017 2026 2020 2023 2017 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alexander A. Maini 490 199 181 112 105 20 979
Rossella Talotta 344 0.7× 111 0.6× 184 1.0× 36 0.3× 136 1.3× 67 1.1k
David Díaz 204 0.4× 366 1.8× 293 1.6× 56 0.5× 110 1.0× 35 984
Namita Sinha 139 0.3× 168 0.8× 442 2.4× 72 0.6× 79 0.8× 71 1.0k
Athan Baillet 395 0.8× 96 0.5× 288 1.6× 28 0.3× 65 0.6× 83 1.6k
Min Ye 172 0.4× 220 1.1× 434 2.4× 38 0.3× 224 2.1× 59 1.3k
C. Edward Rose 604 1.2× 122 0.6× 208 1.1× 35 0.3× 136 1.3× 23 1.3k
Kausik Mandal 337 0.7× 147 0.7× 634 3.5× 37 0.3× 85 0.8× 114 1.7k
Sukriti Sukriti 291 0.6× 450 2.3× 370 2.0× 38 0.3× 66 0.6× 31 1.2k
Robert M. Strieter 524 1.1× 110 0.6× 181 1.0× 135 1.2× 231 2.2× 10 1.0k

Countries citing papers authored by Alexander A. Maini

Since Specialization
Citations

This map shows the geographic impact of Alexander A. Maini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander A. Maini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander A. Maini more than expected).

Fields of papers citing papers by Alexander A. Maini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander A. Maini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander A. Maini. The network helps show where Alexander A. Maini may publish in the future.

Co-authorship network of co-authors of Alexander A. Maini

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander A. Maini. A scholar is included among the top collaborators of Alexander A. Maini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander A. Maini. Alexander A. Maini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Maini, Alexander A., Natalia Bécares, Louise China, et al.. (2021). Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway. JHEP Reports. 3(6). 100332–100332. 7 indexed citations
3.
Flint, Julia, et al.. (2021). Potent anti‐inflammatory effects of an H 2 S‐releasing naproxen (ATB‐346) in a human model of inflammation. The FASEB Journal. 35(10). e21913–e21913. 11 indexed citations
4.
Maini, Alexander A., et al.. (2020). <p>Clinical Characteristics and Predictors of Mortality in Patients with COVID-19 Infection Outside Intensive Care</p>. International Journal of General Medicine. Volume 13. 1157–1165. 14 indexed citations
5.
Bécares, Natalia, Suvi Härmälä, Louise China, et al.. (2019). Immune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality. Clinical Gastroenterology and Hepatology. 18(5). 1207–1215.e6. 11 indexed citations
6.
Bécares, Natalia, Alexander A. Maini, Romain A. Colas, et al.. (2019). FRI-109-Increased plasma leukotriene B4 in decompensated cirrhosis associates with disease progression and leads to increased skin window neutrophil infiltration. Journal of Hepatology. 70(1). e435–e435. 1 indexed citations
7.
China, Louise, Simon S. Skene, Kate Bennett, et al.. (2018). ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial. BMJ Open. 8(10). e023754–e023754. 21 indexed citations
8.
Maini, Alexander A., Richard Hayhoe, Amit A. Patel, et al.. (2018). Monocyte and Neutrophil Isolation, Migration, and Phagocytosis Assays. Current Protocols in Immunology. 122(1). e53–e53. 1 indexed citations
10.
China, Louise, Alexander A. Maini, Simon S. Skene, et al.. (2017). Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease. Clinical Gastroenterology and Hepatology. 16(5). 738–747.e7. 49 indexed citations
11.
China, Louise, Simon S. Skene, Zainib Shabir, et al.. (2017). Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial. Clinical Gastroenterology and Hepatology. 16(5). 748–755.e6. 19 indexed citations
12.
Patel, Amit A., James N. Fullerton, Lies Boelen, et al.. (2017). The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. The Journal of Experimental Medicine. 214(7). 1913–1923. 639 indexed citations breakdown →
13.
Maini, Alexander A., Louise China, Derek W. Gilroy, & Alastair O’Brien. (2017). Progression of cirrhotic liver disease towards acute-on-chronic liver failure triggers changes in innate immune cell phenotype and their response to pro-inflammatory stimuli. Journal of Hepatology. 66(1). S145–S145. 2 indexed citations
14.
Motwani, Madhur P., Frances Bennett, Paul C. Norris, et al.. (2017). Potent Anti‐Inflammatory and Pro‐Resolving Effects of Anabasum in a Human Model of Self‐Resolving Acute Inflammation. Clinical Pharmacology & Therapeutics. 104(4). 675–686. 65 indexed citations
15.
Fullerton, James N., et al.. (2016). Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation. Journal of Visualized Experiments. 6 indexed citations
16.
China, Louise, Nicola Muirhead, Simon S. Skene, et al.. (2016). ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial. BMJ Open. 6(1). e010132–e010132. 6 indexed citations
17.
Fullerton, James N., et al.. (2016). Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation. Journal of Visualized Experiments. 36 indexed citations
18.
Maini, Alexander A., Marc J. George, Madhur P. Motwani, et al.. (2016). A Comparison of Human Neutrophils Acquired from Four Experimental Models of Inflammation. PLoS ONE. 11(10). e0165502–e0165502. 7 indexed citations
19.
Maini, Alexander A., et al.. (2013). Severe alkalosis and hypokalemia with stanozolol misuse. The American Journal of Emergency Medicine. 32(2). 196.e3–196.e4. 7 indexed citations
20.
Herges, Katja, Brigit A. de Jong, Ilan Kolkowitz, et al.. (2012). Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Multiple Sclerosis Journal. 18(4). 398–408. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026